EnLyteRx Expert Video: Depression Linked To Folate Deficiency

Sunset, LA. Jan. 23, 2015 (GLOBE NEWSWIRE) — JayMac Pharmaceuticals, makers of EnLyte, have released an expert video on a natural option for treating depression that may be linked to folate deficiency. Andrew Farah, MD, Chief of Psychiatry of UNC Healthcare, and an expert in the use of B vitamins in mental health, hosts this first in a series of videos: http://youtu.be/Tn170JIBZZ0.

Folate deficiency is related to many conditions including depression, fibromyalgia, chronic fatigue syndrome, ADD/ADHD, and migraine. Click here to read more about folate deficiency. Depression, in particular, is strongly linked to folate deficiency, as folate is critical in producing the chemicals-neurotransmitters-that regulate mood: serotonin, norepinephrine, and dopamine. Research suggests that there is about a 67% increase in depression in people who are folate-deficient.

However, there is a common enzyme defect about 60% of the general U.S. population has, the MTHFR enzyme polymorphism, that makes it harder for the body to break down folic acid from diet or supplements into the form the body can use to make neurotransmitters. Standard antidepressants such as SSRIs and SNRIs come with common side effects like weight gain and sexual dysfunction. About 60% of people don’t finish their recommended course of therapy due to side effects, increasing the need for natural but effective alternatives. Folate therapy is recommended by the American Psychiatric Association and the APA CAM Guidelines as a safe and effective option to be added to existing antidepressant therapy, and EnLyte has a strong following in the medical community.

EnLyte is an FDA-regulated, prescription folate therapy containing L-Methylfolate magnesium, folinic acid, and folacin, plus all of the brain-ready B vitamins: B1, B2, B3, B6, B12, and betaine, zinc, magnesium, vitamin C, and PS Gold omega 3’s. It is gluten free and artificial dye free, and safe for use in pregnancy and lactation.

EnLyte may be used alone or added to certain antidepressants, and is dosed once a day. It is paid for by many insurance plans with an average patient copay of $44, many state Medicaid plans, Tricare for $17, and $58 per month through mail order.

To learn more, visit www.EnLyteRx.Com, or contact EnLyte Customer Care at 985-788-7755.

Angela Hall
JayMac Pharmaceuticals, LLC

– See more at: http://www.globenewswire.com/news-release/2015/01/23/699631/10116775/en/EnLyteRx-Expert-Video-Depression-Linked-To-Folate-Deficiency.html#sthash.euIteIKW.dpuf

eSYNCS | Advertising Agency